Pre-diabetes, insulin resistance, inflammation and CVD risk

This publication has 17 references indexed in Scilit:

• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
  Circulation, 2000
• C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
  New England Journal of Medicine, 2000
• Insulin-Resistant Prediabetic Subjects Have More Atherogenic Risk Factors Than Insulin-Sensitive Prediabetic Subjects
  Circulation, 2000
• C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
  Circulation, 1999
• Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
  New England Journal of Medicine, 1998
• Impact of Diabetes on Mortality After the First Myocardial Infarction
  Diabetes Care, 1998
• NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X
  Diabetologia, 1997
• Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
  New England Journal of Medicine, 1997
• Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
  JAMA, 1990